Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 20/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.40 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.39 |
| ▸ | MPEG1 | Q2M385 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5587817 | 0.95 | ALOX5 (0.41) | ALOX5PTGS2GLS2MPEG1 | |
| SCHEMBL5587560 | 0.89 | ALOX5 (0.41) | ALOX5PTGS2GLS2MPEG1 | |
| SCHEMBL5588313 | 0.83 | ALOX5 (0.49) | ALOX5PTGS2GLS2MPEG1 | |
| SCHEMBL6233544 | 0.75 | ALOX5 (0.43) | ALOX5MPEG1 | |
| SCHEMBL5588228 | 0.73 | ALOX5 (0.46) | ALOX5MPEG1 | |
| SCHEMBL5588730 | 0.73 | ALOX5 (0.40) | ALOX5PTGS2GLS2MPEG1 | |
| SCHEMBL5587232 | 0.73 | ALOX5 (0.40) | ALOX5PTGS2GLS2MPEG1 | |
| SCHEMBL5588503 | 0.72 | CA12 (0.31) | — | |
| SCHEMBL5588914 | 0.71 | ALOX5 (0.41) | ALOX5PTGS2GLS2MPEG1 | |
| SCHEMBL6229354 | 0.70 | ALOX5 (0.44) | ALOX5MPEG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | disclosed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | ALOX5 188/4885PTGS2 3242/4885GLS2 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.